No abstract available
MeSH terms
-
Adrenergic alpha-Antagonists / adverse effects
-
Adrenergic alpha-Antagonists / therapeutic use
-
Adrenergic beta-Antagonists / adverse effects
-
Adrenergic beta-Antagonists / therapeutic use
-
Antihypertensive Agents / adverse effects*
-
Antihypertensive Agents / therapeutic use
-
Benzothiadiazines / adverse effects
-
Benzothiadiazines / therapeutic use
-
Carbohydrate Metabolism
-
Diuresis
-
Diuretics / pharmacology
-
Humans
-
Hypertension / drug therapy*
-
Hypokalemia / chemically induced
-
Kidney Tubules / drug effects
-
Loop of Henle / drug effects
-
Nephrons / drug effects
-
Potassium / metabolism
-
Sodium Chloride Symporter Inhibitors / adverse effects
-
Sodium Chloride Symporter Inhibitors / therapeutic use
-
Sympatholytics / adverse effects
-
Sympatholytics / therapeutic use
-
Uric Acid / metabolism
-
Vasodilator Agents / adverse effects
-
Vasodilator Agents / therapeutic use
Substances
-
Adrenergic alpha-Antagonists
-
Adrenergic beta-Antagonists
-
Antihypertensive Agents
-
Benzothiadiazines
-
Diuretics
-
Sodium Chloride Symporter Inhibitors
-
Sympatholytics
-
Vasodilator Agents
-
Uric Acid
-
Potassium